Picard Medical vs Beyond Air
PMI and XAIR side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PMI and XAIR compare
Picard Medical is the larger company, worth 8.4 times as much as Beyond Air ($16.2M against $1.9M).
Beyond Air grew revenue faster over the last twelve months (60.7% versus 11.6% for Picard Medical).
Picard Medical keeps more of each dollar of sales as profit, with a net margin of −371% compared with −436% at Beyond Air.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PMI | XAIR |
|---|---|---|
| Size and price | ||
| Market cap | $16.2M | $1.9M |
| Share price | $6.91 | $2.01 |
| Change, 1 year | −94.9% | −92.7% |
| Change, 5 years | – | −100.0% |
| Beta (5Y) | −2.18 | −0.20 |
| Employees | 75 | 54 |
| StockData Score | ||
| Total score | 6 | 6 |
| Valuation score | 0 | 3 (better) |
| Growth score | 2 | 2 |
| Performance score | 0 | 0 |
| Health score | 4 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 3.0× | 0.3× (better) |
| P/B | 12.2× | 1.0× (better) |
| FCF yield | – | −1018% |
| Fair value | $3.92 | $12.88 |
| Margin of safety | −76.5% | 84.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 11.6% | 60.7% (better) |
| Revenue growth, 5Y average | – | 54.5% |
| Profitability | ||
| Gross margin | 26.2% (better) | 4.2% |
| Operating margin | −267% (better) | −365% |
| Net margin | −371% (better) | −436% |
| FCF margin | – | −255% |
| Return on equity | −426% (better) | −562% |
| Return on invested capital | −351% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −6.3× |
| Current ratio | 0.99 | 3.31 (better) |
| Altman Z-score | −17.62 | −15.90 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 6.5% | 7.2% |
| Insider net buying, 12 months | – | $287K |
Go deeper
- PMI stock overview
- PMI income statement
- PMI valuation and score
- XAIR stock overview
- XAIR income statement
- XAIR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.